Trial Profile
A Phase II trial comparing Brivudin 0.1% ophthalmic solution with Aciclovir 3 % ophthalmic ointment in the treatment of patients with herpetic dendritic keratitis.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2013
Price :
$35
*
At a glance
- Drugs Aciclovir (Primary) ; Brivudine (Primary)
- Indications Dendritic keratitis
- Focus Therapeutic Use
- Sponsors Menarini Ricerche
- 23 Jun 2012 Additional location (Spain) added as reported by European Clinical Trials Database.
- 09 Jun 2011 New trial record